Quince Therapeutics Inc. (QNCX)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on May 15, 2024, 4:01 pm based on SEC 13F filings Last update: May 15, 2024, 4:01 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Tang Capital Management Kevin C. Tang	2,947,652	$3,124,511	-9%	0.32%
2.	Two Sigma Advisors John Overdeck And David Siegel	97,100	$102,926	-12%	0%
3.	Millennium Management Israel Englander	53,679	$56,900	-10%	0%
4.	ADAR1 Capital Management Daniel Schneeberger	26,829	$28,439		0%
5.	Citadel Investment Group Ken Griffin	26,456	$28,043		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Lamond	$1.04	22,627	Director	2,347,545	2023-12-14	Filing
Lamond	$1.00	22,627	Director	2,324,918	2023-12-13	Filing
Lamond	$1.02	22,327	Director	2,302,291	2023-12-12	Filing
Lamond	$1.00	300	Director	2,279,964	2023-12-12	Filing
Lamond	$1.01	19,123	Director	2,279,664	2023-12-07	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Monohon	$0.98	1,871	Officer	27,440	2023-03-06	Filing
Mcdowell	$2.86	10,800	Officer	122,500	2022-06-06	Filing
Mcloughlin	$88.93	1,000	Director	0	2021-10-08	Filing
Lowe	$98.50	4,963	Officer	60,000	2021-10-05	Filing
Mcloughlin	$98.90	48	Director	0	2021-08-16	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Vanguard Group Inc	971,801	$1,020,391	0%
2.	Epiq Capital Group, Llc	870,133	$913,639	0.41%
3.	Blackrock Inc.	335,604	$352,384	0%
4.	Geode Capital Management, Llc	261,738	$274,897	0%
5.	Alphabet Inc.	189,122	$198,578	0%